Format

Send to

Choose Destination
Psychiatr Genet. 2011 Aug;21(4):208-11. doi: 10.1097/YPG.0b013e328341e069.

Novel variants of the SHANK3 gene in Japanese autistic patients with severe delayed speech development.

Author information

1
Department of Neurochemistry, National Institute of Neuroscience, Tokyo, Japan.

Abstract

The 22q13.3 deletion syndrome is characterized by a significant delay in language development, mental retardation, hypotonia, and autistic features. Cumulative evidence has shown that haploinsufficiency of the SHANK3 gene is a major cause of the neurological symptoms of the 22q13.3 deletion syndrome. Shank3, a multidomain protein containing the SH3 and PDZ domains, is thought to play an important role in the formation and function of synapses in the developing brain. In this study, we analyzed the SHANK3 gene in 128 autistic patients with manifestations similar to those seen in the 22q13.3 deletion syndrome. The results showed a 6-amino acid deletion upstream of the SH3 domain, a missense variant (arginine to histidine at amino acid position 656) in the PDZ domain, and the insertion or deletion of a repeated 10-bp GC sequence located 9-bp downstream from the 3' end of exon 11. None of these variants was found in 228 controls.

PMID:
21378602
DOI:
10.1097/YPG.0b013e328341e069
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center